0.37Open0.37Pre Close0 Volume490 Open Interest20.00Strike Price0.00Turnover0.00%IV705.14%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.37Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma6.84Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Nkarta Stock Discussion
boom boom boom boom 💥 getting richer from my room 🤣
$Nkarta (NKTX.US)$
$Nkarta (NKTX.US)$
I don't know why I didn't share it in my previous post or why I just thought to share it now 🤷🏽 but here we go. this is what I shared with the group.
I know i said not to buy ibrx because it was too volatile. I've changed my tune because of my biopharma outlook.... want it's twin?
cancer killing cell developer, starting with leukemia! buy rating at 17 (i think it pops to 23, but 19 is the full extension) 👌
see that daily turnaround? that's a bottom
see the accumulation at th...
I shared this with my group. I like cancer treatment biostocks 😁
$Nkarta (NKTX.US)$
Biotech stocks remain depressed, nearly two years into a dip that has seen the SPDR S&P Biotech ETF XBI 0.05% drop nearly 50%.
The other most-watched exchange-traded fund that tracks the biotech secto...
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S (ASND.US)$
$Vaxcyte (PCVX.US)$
$Legend Biotech (LEGN.US)$
$Janux Therapeutics (JANX.US)$
$Aerovate (AVTE.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Evolent Health (EVH.US)$
$NewAmsterdam Pharma (NAMS.US)$
$RxSight (RXST.US)$
$TYRA BIOSCIENCES, INC. (TYRA.US)$
$Edgewise Therapeutics (EWTX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Biogen (BIIB.US)$
$PepGen (PEPG.US)$